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The enveloped positive single-stranded RNA hepatitis C virus
(HCV), classiﬁed in the genus Hepacivirus within the family
Flaviviridae, is the major cause of liver disease. With an estimated
170 to 200 million people infected worldwide [1], its high persistence,
no protective vaccine available at present and limited current
therapeutic agents, this disease has emerged as a serious healthcare
problem on a global scale [2]. The variability of the HCV proteins gives
the virus the ability to escape the host immune surveillance system
and notably hampers the development of an efﬁcient vaccine.
HCV has a single-stranded genomewhich encodes a polyprotein of
about 3010 amino acids, which is cleaved by a combination of cellular
and viral proteases to produce the mature proteins [3]. HCV entry intothe host cell is achieved by the fusion of viral and cellular membranes,
its replication cycle is highly dependent on host cell lipids, and the
morphogenesis has been suggested to take place in the endoplasmic
reticulum [4]. Details about HCV replication process remain largely
unclear, but most if not all of the HCV non-structural proteins (NS)
proteins are involved [3]. NS proteins include two viral proteases, NS2
and NS3, responsible for the maturation of all the NS proteins [5]. NS3
is a multifunctional protein with a RNA helicase/NTPase domain apart
from the serine protease domain [6]. The NS4A protein, an integral
membrane protein, which is predicted to contain at least four
transmembrane domains, serves as a cofactor for NS3 and is
incorporated as an integral component into the enzyme core. NS4B
is an integral membrane protein which seems to be implicated in the
formation of the replication complex within the endoplasmic
reticulummembranes [7], as well as is also engaged in virus assembly
and release [8]. The NS5B RNA-dependent RNA polymerase is the
catalytic subunit of the viral replication complex [9].
NS5A is a membrane-anchored phosphoprotein which is indis-
pensable for replication, essential for efﬁcient virus assembly and has
been suggested to be involved in interferon resistance and apoptotic
regulation [10–12]. Although numerous functions have been sug-
gested for NS5A, its ultimate function/s in the HCV life cycle is/are not
known. However, NS5A is an absolutely required component of the
viral replicase and has been recognised as a promising therapeutic
target [13]. NS5A contains three domains, and has been observed in
two forms, phosphorylated and hyper-phosphorylated [14]. It has
been shown that domain I has a tight association with the membrane,
association mediated post-translationally by a segment within the
N-terminal fragment of NS5A [15] (Fig. 1A). This segment has been
proposed to be an amphipathic α-helix [16,17]. The helix deﬁnes a
Fig. 1. (A) Schematic representation of HCV NS5A protein showing the proposed location of domains I, II and III, the low-complexity sequences (LCS) I and II, as well as the amino
terminal amphipathic helix [61]. Numbers refer to amino acid numbering of NS5A 1b_HC-J4. (B) Membrane leakage elicited by the HCV NS5A 1b_HC-J4 peptide library on model
membranes composed of EPC/ESM/Chol at a phospholipid molar ratio of 5:1:1, and a complex lipid composition resembling the ER membrane (upper and lower histograms,
respectively). Vertical bars indicate standard deviations of the mean of triplicate samples. (C) Relative location of the 64 18-mer peptides derived from the HCV NS5A 1b_HC-J4
protein is shown with respect to the sequence of the protein. Maximum overlap between adjacent peptides is 11 amino acids. (D) Correlation of the HCV NS5A-derived peptide
library with the peptide library and sequences of the peptides 1A and 1B used in this study. (E) Sequence of the NS5A peptides 1A and 1B used in this work, along the consensus
sequence obtained using twenty-eight NS5A sequences from the six main HCV genotypes.
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essential for the formation of a functional HCV replication complex [18].
The introduction of mutations into the hydrophobic face of the N-
terminal segment of NS5A has a critical consequence that generate the
inhibition of HCV RNA replication, hence the importance of the
segment-membraneassociation for theviral life cycle [19]. Interestingly,
an amphipathic helical peptidederived from theN-terminal fragment of
NS5A has been shown to be virocidal against HCV [20].
Previous studies from our group studying the effect of glycoprotein-
derived peptide libraries on model membrane integrity have helped us
tounderstand themechanismsunderlying the interactionbetweenviral
proteins and membranes [21–23]. In the present study, we report the
binding and interaction of two peptides corresponding to the N-
terminal segment of proteinNS5A from two strains, namely 1a_H77 and
1b_HC-J4, and deﬁne it as a membrane interacting domain. We
show that this segment strongly partitions into phospholipid mem-
branes, interacts with them, and is located in a shallow position in themembrane. These results would suggest that this NS5A element is an
essential constituent of the interaction between the protein and the
membrane and might shed light into the speciﬁc function of the NS5A
protein in the viral cycle.
2. Materials and methods
2.1. Materials and reagents
One set of 64 peptides derived from theHCV 1b_HC-J4 NS5A protein
was obtained through the NIH AIDS Research and Reference Reagent
Program(DivisionofAIDS,NIAID,NIH,Bethesda,MD). Peptides 1A(HCV
strain 1a_H77, sequence 3SWLRDIWDWICEVLSDFK20) and 1B (HCV
strain 1b_HC-J4, sequence 3SWLRDVWDWICTVLTDFK20) were synthe-
sized with N-terminal acetylation and C-terminal amidation on an
automatic multiple synthesizer (Genemed Synthesis, San Antonio, TX,
USA). The peptides were puriﬁed by reverse-phase high-performance
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1 ml/min, solventA, 0.1% triﬂuoroacetic acid, solvent B, 99.9 acetonitrile
and 0.1% triﬂuoroacetic acid) to N95% purity, and its composition and
molecular mass were conﬁrmed by amino acid analysis and mass
spectrometry. Since triﬂuoroacetate has a strong infrared absorbance at
approximately 1673 cm−1, which interferes with the characterization
of the peptide Amide I band [24], residual triﬂuoroacetic acid, used both
in peptide synthesis and in the high-performance liquid chromatogra-
phymobile phase, was removed by several lyophilisation/solubilisation
cycles in 10 mM HCl [25]. Peptides were solubilized in water/TFE at
50% v/v). Bovine brain phosphatidylserine (BPS), bovine liver L-α-
phosphatidylinositol (BPI), cholesterol (Chol), egg phosphatidic acid
(EPA), egg L-α-phosphatidylcholine (EPC), egg sphingomyelin (ESM),
egg trans-esteriﬁed L-α-phosphatidylethanolamine (TPE), tetramyris-
toyl cardiolipin (CL), 1,2-dimyristoylphosphatidylserine (DMPS), 1,2-
dimyristoylphosphatidic acid (DMPA), 1,2-dimyristoylphosphatidyl-
choline (DMPC) and 1,2-dimyristoylphosphatidylglycerol (DMPG)
were obtained from Avanti Polar Lipids (Alabaster, AL, USA). The lipid
composition of the synthetic endoplasmic reticulum was EPC/CL/BPI/
TPE/BPS/EPA/ESM/Chol at a molar ratio of 59:0.37:7.7:18:3.1:1.2:3.
4:7.8 [26]. 5-Carboxyﬂuorescein (CF, N95% by HPLC), 4-(2-(6-(diocty-
lamino)-2-naphthalenyl)ethenyl)-1-(3-sulfopropyl)-pyridinium inner
salt (di-8-ANEPPS), 5-doxyl-stearic acid (5-NS), 16-doxyl-stearic acid
(16-NS), ﬂuorescein isothiocyanate labeled dextran FD-10, deuterium
oxide (99.9%), Triton X-100, EDTA and HEPES were purchased from
Sigma-Aldrich (Madrid, ES). 1,6-Diphenyl-1,3,5-hexatriene (DPH), and
1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-
DPH) were obtained from Molecular Probes (Eugene, OR). All other
chemicals were commercial samples of the highest purity available
(Sigma-Aldrich, Madrid, ES). Water was deionized, twice-distilled and
passed through a Milli-Q equipment (Millipore Ibérica, Madrid, ES) to a
resistivity higher than 18 MΩ cm.
2.2. Vesicle preparation
Aliquots containing the appropriate amount of lipid in chloro-
form–methanol (2:1 vol/vol) were placed in a test tube, the solvents
were removed by evaporation under a stream of O2-free nitrogen, and
ﬁnally, traces of solvents were eliminated under vacuum in the dark
for N3 h. The lipid ﬁlms were resuspended in an appropriate buffer
and incubated either at 25 °C or 10 °C above the phase transition
temperature (Tm) with intermittent vortexing for 30 min to hydrate
the samples and obtain multilamellar vesicles (MLV). The samples
were frozen and thawed ﬁve times to ensure complete homogeniza-
tion and maximization of peptide/lipid contacts with occasional
vortexing. Large unilamellar vesicles (LUV) with a mean diameter of
0.1 μm (leakage measurements) and 0.2 μm (dextran release assays)
were prepared from MLV by the extrusion method [27] using
polycarbonate ﬁlters with a pore size of 0.1 and 0.2 μm (Nuclepore
Corp., Cambridge, CA, USA). For infrared spectroscopy, aliquots
containing the appropriate amount of lipid in chloroform/methanol
(2:1, v/v) were placed in a test tube containing 200 μg of dried
lyophilized peptide. After vortexing, the solvents were removed by
evaporation under a stream of O2-free nitrogen, and ﬁnally, traces of
solvents were eliminated under vacuum in the dark for more than
three hours. The samples were hydrated in 100 µl of D2O buffer
containing 20 mM HEPES, 100 mM NaCl, 0.1 mM EDTA, pH 7.4 and
incubated at 10 °C above the Tm of the phospholipid mixture with
intermittent vortexing for 45 min to hydrate the samples and obtain
MLV. The samples were frozen and thawed as above. Finally the
suspensions were centrifuged at 15,000 rpm at 25 °C for 15 min to
remove the possibly peptide unbound to the membranes. The pellet
was resuspended in 25 μl of D2O buffer and incubated for 45 min at
10 °C above the Tm of the lipid mixture, unless stated otherwise. The
phospholipid and peptide concentration were measured by methods
described previously [28,29].2.3. Membrane leakage and peptide binding to vesicles
LUVs with a mean diameter of 0.1 μm were prepared as indicated
above in buffer containing 10 mM Tris, 20 mM NaCl, pH 7.4, and CF at
a concentration of 40 mM. Non-encapsulated CF was separated from
the vesicle suspension through a Sephadex G-75 ﬁltration column
(Pharmacia, Uppsala, SW, EU) eluted with buffer containing 10 mM
Tris, 100 mM NaCl, and 1 mM EDTA, pH 7.4. Membrane rupture
(leakage of intraliposomal CF) was assayed by treating the probe-
loaded liposomes (ﬁnal lipid concentration, 0.125 mM) with the
appropriate amounts of peptide on microtiter plates using a
microplate reader (FLUOstar; BMG Labtech, Offenburg, Germany),
stabilized at 25 °C with the appropriate amounts of peptide, each well
containing a ﬁnal volume of 170 µl. The medium in the microtiter
plates was continuously stirred to allow the rapid mixing of peptide
and vesicles. In the case of LUVs (0.2 μm) encapsulated with
ﬂuorescent dextran FD10, the lipid was resuspended to a concentra-
tion of 100 mg/ml solution of dextrans in buffer containing 10 mM
Tris, 100 mM NaCl, pH 7.4. Non-encapsulated dextrans were removed
by gel-ﬁltration chromatography using a pump P-50 (Amershan
Pharmacia Biotech AB, Uppsala, Sweden) with a Sephacryl® 500-HR
column eluted with the same buffer above described, at a ﬂow
rate of 3 ml/min. The ﬁnal lipid concentration was 0.075 mM in a
5 mm×5 mm ﬂuorescence cuvette (ﬁnal volume of 400 µl), stabilized
at 25 °C and under constant stirring. Fluorescence was measured
using a Varian Cary Eclipse spectroﬂuorimeter. One hundred percent
release was achieved by adding Triton X-100 to either the microtiter
plate or the cuvette to ﬁnal concentration of 0.5% (w/w). Changes in
ﬂuorescence intensity were recorded with excitation and emission
wavelengths set at 492 and 517 nm, respectively. Excitation and
emission slits were set at 5 nm. Leakage was quantiﬁed on a
percentage basis as previously described [30,31]. The mole fraction
partition coefﬁcient Kp, i.e., the amount of peptide in the bilayer as a
fraction of the total peptide present in the system, was evaluated by
the enhancement of the tryptophan ﬂuorescence by successive addi-
tions of small volumes of LUV to a peptide sample (2.15×10−5 M) as
described previously [32]. Fluorescence spectra were recorded in a
SLM Aminco 8000C spectroﬂuorometer with excitation and emission
wavelengths of 290 and 348 nm, respectively, and 4 nm spectral
bandwiths. Measurements were carried out in 10 mM Tris, 100 mM
NaCl, and EDTA 0.1 mM, pH 7.4. Intensity values were corrected for
dilution, and the scatter contribution was derived from lipid titration
of a vesicle blank.
2.4. Acrylamide quenching of Trp emission, quenching with lipophylic
depth probes and steady-state ﬂuorescence anisotropy
Aliquots from a 4 M solution of the water-soluble quencher were
added to the solution-containing peptide in the presence and absence
of liposomes at a peptide/lipid molar ratio of 1:100. The results
obtained were corrected for dilution and the scatter contribution was
derived from acrylamide titration of a vesicle blank. Aliquots of TMA-
DPH or DPH in N,N′-dimethylformamide were directly added into
MLVs formed in 10 mM Tris, 100 mM NaCl, EDTA 0.1 mM, pH 7.4 to
obtain a probe/lipid molar ratio of 1/500. Samples were incubated for
15 or 60 min when TMA-DPH or DPH were used, respectively, 10 °C
above the gel to liquid crystalline phase transition temperature Tm of
the phospholipid mixture. Afterwards, the peptides were added to
obtain a peptide/lipid molar ratio of 1:15 and incubated 10 °C above
the Tm of each lipid for one hour, with occasional vortexing. All
ﬂuorescence studies were carried using 5 mm×5 mm quartz cuvettes
in a ﬁnal volume of 400 µl (315 μM lipid concentration). The steady-
state ﬂuorescence anisotropy was measured with an automated
polarization accessory using a Varian Cary Eclipse ﬂuorescence
spectrometer, coupled to a Peltier for automatic temperature change.
Samples were excited at 360 nm (slit width, 5 nm) and ﬂuorescence
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studies with lipophylic probes were performed by successive addition
of small amounts of 5-NS or 16-NS in ethanol to peptide samples
incubated with LUV. The ﬁnal concentration of ethanol was kept
below 2.5% (v/v) to avoid any signiﬁcant bilayer alterations. After
each addition an incubation period of 15 min was kept before the
measurement. The data were analyzed as previously described [31].
The Stern–Volmer quenching constant, Ksv, obtained from the Stern–
Volmer equation, represents the quencher concentration at which
50% of the intensity is quenched and it is therefore a measure of the
accessibility of Trp to the quencher molecule [33].
2.5. Measurement of the membrane dipole potential using
Di-8-ANEPPS-labeled membranes
Aliquots containing the appropriate amount of lipid in chloro-
form–methanol (2:1 vol/vol) and di-8-ANEPPS were placed in a test
tube to obtain a probe/lipid molar ratio of 1/100 and LUVs, with a
mean diameter of 90 nm, were prepared as described previously.
Steady-state ﬂuorescencemeasurements were recordedwith a Varian
Cary Eclipse spectroﬂuorimeter. Dual wavelength recordings with the
dye di-8-ANEPPS were obtained by exciting the samples at two
different wavelengths (450 and 520 nm) and measuring their
intensity ratio, R(450/520), at an emission wavelength of 620 nm
[34,35]. Changes in the total membrane dipole moment cause a shift
in the excitation spectrum maximum of di-8-ANEPPS. The lipid
concentration was 200 µM, and all experiments were performed at
25 °C.
2.6. Differential scanning calorimetry
MLVs were formed as stated above in 20 mM HEPES, 100 mM Na
Cl, 0.1 mM EDTA, pH 7.4. The peptide was added to obtain a peptide/
lipid molar ratio of 1:15. The ﬁnal volume was 1.2 ml (0.5 mM lipid
concentration), and incubated 10 °C above the Tm of each phospho-
lipid for 1 h with occasional vortexing. Samples were loaded into the
calorimetric cell. DSC experiments were performed in a VP-DSC
differential scanning calorimeter (MicroCal LLC, MA) under a constant
external pressure of 30 psi in order to avoid bubble formation, and
samples were heated at a constant scan rate of 60 °C/h. Experimental
data were corrected from small mismatches between the two cells by
substracting a buffer baseline prior to data analysis. The excess heat
capacity functions were the analyzed by using Origin 7.0 (Microcal
Software). The thermograms were deﬁned by the onset and
completion temperatures of the transition peaks obtained from
heating scans. In order to avoid artifacts due to the thermal history
of the sample, the ﬁrst scan was never considered; second and further
scans were carried out until a reproducible and reversible pattern was
obtained.
2.7. Magic angle spinning (MAS) 31P NMR
Samples were prepared as described above and concentrated by
centrifugation (14,000 rpm for 15 min). MAS 31P NMR spectra were
acquired on a Bruker 500 MHz Avance spectrometer (Bruker BioSpin,
Rheinstetten, Germany) using a Bruker 4-mm broad band MAS probe
under both static and MAS conditions. The samples were packed into
4-mm zirconia rotors and placed in the spinning module of the MAS
probe; no cross-polarization was used. The spinning speed was
10 kHz, regulated to ±3 Hz by a Bruker pneumatic unit and the
temperature was 15 °C. A single 31P 90° pulse (typically 5 µs) was
used for excitation, a gated broadband decoupling of 10 W, 32 k data
points, 3600 transients and 3 s delay time between acquisitions.
Under static conditions, the samples showed a broad asymmetrical
signal with a low-frequency peak and a high-frequency shoulder
characteristic of bilayer structures (data not shown).2.8. Infrared spectroscopy
Approximately 25 µl of a pelleted sample in D2O was placed
between two CaF2 windows separated by 50-µm thick Teﬂon spacers
in a liquid demountable cell (Harrick, Ossining, NY). The spectra were
obtained in a Bruker IFS55 spectrometer using a deuterated triglycine
sulfate detector. Each spectrum was obtained by collecting 200
interferograms with a nominal resolution of 2 cm−1, transformed
using triangular apodization and, in order to average background
spectra between sample spectra over the same time period, a sample
shuttle accessory was used to obtain sample and background spectra.
The spectrometer was continuously purgedwith dry air at a dew point
of −40 °C in order to remove atmospheric water vapour from the
bands of interest. All samples were equilibrated at the lowest
temperature for 20 min before acquisition. An external bath circula-
tor, connected to the infrared spectrometer, controlled the sample
temperature. For temperature studies, samples were scanned using
2 °C intervals and a 2-min delay between each consecutive scan. The
data were analyzed as previously described [30,36].
3. Results
HCV NS5A protein is a 447 amino acid phosphoprotein, which is
divided into three domains interconnected by two connecting loops
(Fig. 1A). The NS5A sequence comprising amino acids 1 to 27
corresponds to the proposed amphipathic α-helix which should
mediate membrane in-plane association of the protein to the
membrane [15–17]. Additionally, a peptide corresponding to amino
acid sequence from 3 to 20 of genotype 1a HCV NS5A has been shown
to destabilize membranes as well as present virocidal activity against
HCV [20]. In order to ﬁnd any sequence within NS5A which might
interact with the membrane, we have studied the effect of a HCV
1b_HC-J4 NS5A-derived peptide library on membrane rupture by
monitoring the CF leakage from two different liposome compositions.
The ﬁrst one has been the lipid mixture composed of EPC/ESM/Chol
at a phospholipid molar ratio of 5:1:1, and the second one resembles
the ER membrane (EPC/CL/BPI/TPE/BPS/EPA/ESM/Chol at a molar
ratio of 59:0.37:7.7:18:3.1:1.2:3.4:7.8, [26]). The peptide library used
in this study and their correlation with the HCV NS5A protein
sequence is depicted in Fig. 1C. Two and three consecutive peptides in
the library have an overlap of 11 and 4 amino acids, respectively. Note
that the NS5A-derived peptides include the whole HCV NS5A protein
sequence (residues 1 to 447, NS5A numbering). When the NS5A-
derived peptides were assayed on liposomes, some exerted an
important leakage effect as seen in Fig. 1B. The most remarkable
effect was observed for the ﬁrst three peptides in the library, i.e.,
peptides comprising amino acid residues from−5 to 13, from 3 to 20
and from 10 to 27 (Fig. 1D). These peptides produced leakage values
for both types of liposomes between 60 and 100%, depending on the
speciﬁc lipid composition of the liposomes (Fig. 1B). It is interesting to
note that, apart from these three peptides, no signiﬁcant leakage was
elicited for any other of the peptides in both liposome systems
(Fig. 1B). Peptide comprising amino acids 3 to 20, which completely
disrupted both types of membranes, posses common hydrophobic
and hydrophilic positions for all HCV genotypes, demonstrating its
amphipathic nature (Table 1 and [37]). Taking into account these
results, as well as the above mentioned literature data concerning the
membrane-mediated HCV replication process which involve many if
not all of the HCV NS proteins, we have performed an in-depth study
of the interaction of the NS5A segment comprising residues 3 to 20
with membrane model systems. In order to discern any differences
between related sequences of NS5A proteins, we have studied two
peptides from genotypes 1a_H77 HCV NS5A (peptide 1A) and 1b_HC-
J4 HCV NS5A (peptide 1B) (their sequences are displayed in Fig. 1E).
We have investigated their binding and interaction with different
membrane model systems, as well as characterized the structural
Table 1
Alignment (clustalw2) for reference strains representing the major genotypes of
hepatitis C virus. Alignment of residues 3–20 (HCV NS5A numbering) is only shown.
The consensus sequence is shown beneath the alignment. Symbols * and : stand for
identical and highly conserved residues, respectively. The sequences studied in this
work are emphasized in bold.
Genotype and strain Sequence
1a_H77 SWLRDIWDWICEVLSDFK
1c_HC-G9 SWLKDVWDWICEVLSDFK
6h_VN004 SWLRDIWDWVCEVLSDFK
6a_6a33 SWLRDVWDWVCTVLSDFK
6b_Th580 SWLRDVWDWVCTVLSDFK
6t_D49 SWLRDVWDWVCTVLSDFK
6d_VN235 SWLKDVWDWVCTVLSDFK
6e_D42 SWLRDVWDWVCMVLSDFK
4f_CM_DAV9905 SWLWEIWDWVCTVLSDFK
4d_24 SWLWEIWDWVCTVLSDFK
4a_ED43 SWLWEVWDWVLHVLSDFK
1g_1804 SWLSEIWDWICTVLSDFK
4k_PB65185 SWLREVWDWVCTVLTDFK
6c_Th846 TWLREVWDWVCTVLSDFK
1b_Con1 SWLRDVWDWICTVLTDFK
1b_HC-J4 SWLRDVWDWICTVLTDFK
2i_D54 SWLWDVWDWICSILTDFK
2c_BEBE1 SWLRDVWDWVCSILIDFK
2a_HC-J6 SWLRDVWDWVCTILTDFK
2k_VAT96 SWLRDIWDWACTILTDFK
6o_D85 SWLRDIWDWVCTVLSDFK
6f_C-0044 SWLRDIWDWVCTVLSDFK
6k_VN405 SWLRDIWDWVCTVLSDFK
6g_JK046 TWLRDIWDWVCTVLSDFR
5a_EUH1480 TWLRAIWDWVCTALTDFK
3a_NZL1 DWLRTIWDWVCSVLADFK
3b_Tr-Kj DWLHDIWDWVCIVLSDFK
3k_JK049 NWLYDIWNWVCTVLADFK
Consensus ** :*:* * **:
Fig. 2. Change on the ﬂuorescence intensity of the Trp residues of the NS5A-derived
peptides 1A (A) and 1B (B) in the presence of increasing lipid concentrations. The lipid
compositions used were EPC/ESM/CHOL at a molar ratio of (5:1:1) (●), EPC/CHOL at a
molar ratio of 5:1 (▲), synthetic ER membranes (▼), BPS/CHOL at a molar ratio of 5:1
(■) and EPC (♦). Vertical bars indicate standard deviations of the mean of triplicate
samples.
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molecules.
The ability of the NS5A 1A and 1B peptides to interact with
membranes was determined from ﬂuorescence studies of the peptide
intrinsic Trp residues in presence of model membranes [38] contain-
ing different phospholipid compositions at different lipid/peptide
ratios (Fig. 2). In order to observe any speciﬁc interaction of the
peptides with any speciﬁc type of lipid, the model membranes were
composed of zwitterionic and negatively charged phospholipids as
well as SM and Chol at different molar ratios. The presence of both SM
and Chol has been related to the occurrence of laterally segregated
membrane microdomains or “lipid rafts”. Interestingly, it has been
shown that active replication complexes of HCV might be localized in
lipid rafts [39,40]. The change in the Trp ﬂuorescent spectral
properties in the presence of phospholipids indicates that the
peptides interact with these model membranes. The Trp ﬂuorescence
intensity of both peptides increased upon increasing the lipid/peptide
ratio, indicating a signiﬁcant change on the environment of the Trp
moiety of the peptides (Fig. 2A and B). For both peptides, partition
constant (Kp) values in the range 105 were obtained for the different
phospholipid compositions studied (Table 2), indicating that the
peptides were bound to the membrane with high afﬁnity [38,41].
Interestingly, differences in ﬂuorescence intensity were also observed,
since the increase of intensity was higher in zwitterionic membranes
than in the presence of model membranes containing the negatively
charged phospholipid BPS (Fig. 2). Differences in the ﬂuorescence
anisotropy values of the peptides were also observed in the presence
of phospholipid model membranes. It was found that addition of
liposomes to the 1A and 1B peptides increased signiﬁcantly the Trp
anisotropy values (from about 0.06–0.07 in solution to a limiting
value of 0.19–0.22 in the presence of membranes), indicating a
signiﬁcant motional restriction of the Trp moieties of the peptides at a
relatively high lipid/peptide ratio. The NS5A 1A and 1B peptides havea negative net formal charge of −2 and −1 respectively, so it is
reasonable to assume that an electrostatic repulsion with membranes
composed of negatively charged phospholipids modulates the
location of the peptides in the membrane. Because of this, the
increase of Trp ﬂuorescence in the presence of anionic membranes is
lower than in the presence of membranes containing zwitterionic
phospholipids.
To explore the effect of the NS5A peptides 1A and 1B in the
destabilization of membrane vesicles, we studied their effect on the
release of the encapsulated ﬂuorophores CF and FD10 (Stokes radius
around 6 Å and 23 Å, respectively) in model membranes [42,43]. The
extent of CF leakage observed at different peptide to lipid molar ratios
and the effect on different phospholipid compositions is shown in
Fig. 3A and B, where it can be seen that the peptides were able to
induce the release of the internal contents of the liposomes in a dose-
dependent manner. It is interesting to note that the NS5A 1A and 1B
peptides induced a high percentage of leakage (60–90%), even at
lipid/peptide ratios as high as 30:1, for liposome compositions of EPC/
Chol at molar ratios of 5:1 and 5:3, EPC/ESM/Chol at molar ratios of
5:1:1 and 5:3:1, and EPC (Fig. 3A). In the case of the ER complex
Table 2
Partition coefﬁcients, Stern–Volmer quenching constants and maximal leakage values for the NS5A 1A and 1B peptides incorporated in LUVs of different compositions.
Peptide 1A 1B 1A 1B 1A 1B 1A 1B 1A 1B 1A 1B
Kp (×10−5 M−1) Trp Ksv (M−1)
acrylamide
Ksv (M−1) 5-NS Ksv (M−1) 16-NS CF leakage
(max%)
FD10 leakage
(max%)
LUV compositions EPC 4.77±0.62 2.16±0.32 1.29 1.87 22.38 27.89 5.01 9.26 87 65 89 96
ER 2.88±0.38 1.12±0.15 0.99 0.89 – – – – 72 38 65 81
EPC/SM/Chol
5:1:1
3.17±0.51 3.17±0.45 2.19 1.53 44.05 56.03 20.12 15.44 76 67 26 9
EPC/Chol
5:1
3.19±0.53 1.79±0.38 2.34 1.86 43.14 36.90 4.26 17.75 81 79 21 8
BPS/Chol
5:1
4.73±0.98 1.46±0.78 2.82 2.12 – – – – 25 16 – –
Buffer – – 10.17 9.18 – – – – – – – –
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compared to peptide 1B (about 70% leakage value for peptide 1A and
about 35% for peptide 1B). The leakage values observed for liposomes
composed of the negatively charged phospholipids BPS and EPA (BPS/
Chol and EPA/Chol at molar ratios of 5:1) were much lower as
observed in Fig. 3A and B (leakage values between 5 and 20%). These
data show that the interaction of peptides 1A and 1B is signiﬁcantly
higher for liposomes containing mainly zwitterionic phospholipids
than negatively charged ones. Although there is no clear relationship
between membrane binding and CF leakage, a relatively good
relationship exists between the Trp ﬂuorescence intensity of the
peptides and CF leakage, i.e., the higher the ﬂuorescence intensityFig. 3. Effect of theNS5A-derivedpeptides 1A and 1Bon the release (membrane rupture) of CF
were EPC/ESM/CHOLat amolar ratio of 5:1:1 (●), EPC/CHOLat amolar ratioof 5:1 (▲), synthe
ratio of 5:1 (Y), EPC/CHOL at a molar ratio of 5:3 ( a) and EPC/ESM/CHOL at a molar ratio ochange, the higher the leakage (data not shown). If we suppose that
the ﬂuorescence intensity of the Trp residues is related to the peptide
location in the membrane [33], the peptides insert more deeply in
membranes composed of zwitterionic phospholipids than on mem-
branes composed of negatively charged ones. If that were true, the
deeper location of the peptides, the higher the CF leakage is. Peptides
1A and 1B were also able of inducing leakage of ﬂuorophores larger
than CF, such as FD10 (Fig. 3C and D). Signiﬁcant leakage values were
observed for liposomes composed of EPC and ER (95–65% maximum
leakage values for peptide 1A and 96–80% for peptide 1B). However,
leakage values for liposomes composed of EPC/Chol at a molar ratio
of 5:1 and EPC/ESM/Chol at a molar ratio of 5:1:1 were very low(A and B) and FD10 (C andD) for different lipid compositions. The lipid compositions used
tic ERmembranes (▼), BPS/CHOLat amolar ratioof 5:1 (■), EPC (♦), EPA/CHOLat amolar
f 5:3:1(). Vertical bars indicate standard deviations of the mean of triplicate samples.
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peptide 1B), suggesting that Chol decreases the permeability to FD10.
As it has been commented previously, this effect could be explainedFig. 4. Stern–Volmer plots for the quenching of the ﬂuorescence of the Trp residues of peptid
emission of peptides 1A (C) and 1B (D) by 5-NS (ﬁlled symbols) and 16-NS (empty symbols
through the ﬂuorescence ratio (R) of di-8-ANEPPS in the presence of LUVS containing differ
used were: EPC/ESM/Chol at a molar ratio of 5:1:1 (●), EPC/Chol at a molar ratio of 5:1 (▲),
in buffer are represented by (○). The lipid to peptide ratio was 100:1 for the experimentsby the effect of Chol on the different location of the peptides (see
above), membrane curvature, different peptide translocation and/or
peptide aggregation [44]. Therefore peptides 1A and 1B are capable ofes 1A (A) and 1B (B) by acrylamide, depth-dependent quenching of the Trp ﬂuorescence
) and effect of peptides 1A (E) and 1B (F) on the membrane dipole potential monitored
ent lipid compositions at different lipid-to-peptide molar ratios. The lipid compositions
synthetic ERmembranes (▼), BPS/Chol at a molar ratio of 5:1 (■), and EPC (♦). Peptides
using acrylamide and NS probes.
Fig. 5. Steady-state anisotropy, brN, of TMA-DPH (A, C, E, G, I and K) and DPH (B, D, F, H, J and L) incorporated into (A and B) DMPC, (C and D) DMPG, (E and F) DMPS, (G and H) DPPC,
(I and J) DMPA, and (K and L) ER model membranes as a function of temperature. Data correspond to vesicles containing pure phospholipids (○) and phospholipids plus NS5A 1A
(●) or 1B (■) derived peptides. The peptide to phospholipid molar ratio was 1:15. The ER complex mixture contained DMPC instead of EPC (see text for details).
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Fig. 6. DSC heating thermograms for model membranes composed of (A) DMPC,
(B) DMPG and (C) DEPE in the absence (upper curves) and in the presence of NS5A
peptide 1A (middle curve) and peptide 1B (lower curve) at a phospholipid/peptide
molar ratio of 15:1. All the thermograms are normalized to the same amount of lipid.
(D) MAS 31PNMR at 15 °C and 10 kHz spinning speed (500 MHz proton frequency)
spectra for EPC/ESM at a molar ratio of 5:1 multilamellar suspension in the presence of
peptides 1A and 1B at a phospholipid/peptide molar ratio of 15:1 as indicated. The
original, the ﬁtted envelope and the ﬁtted curves are shown in the upper, middle and
lower panels respectively.
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composition, a complete disruption of the membrane is attained
only at high peptide-to-lipid ratios [45,46].
To investigate the accessibility of the Trp residues of the NS5A 1A
and 1B peptides to the aqueous phase in the presence of model
membranes, we used acrylamide, an efﬁcient water-soluble neutral
quencher probe. Stern–Volmer plots for the quenching of Trp by
acrylamide, recorded in the absence and presence of model
membranes, are shown in Fig. 4A and B and the resultant Stern–
Volmer constants are presented in Table 2. Linear Stern–Volmer plots
indicate that the Trp residue is fairly accessible to acrylamide, and in
all cases, the quenching of the peptide Trp residue showed an
acrylamide dependent concentration behaviour. In aqueous solution
the Trp residues were highly exposed to the solvent that led to a more
efﬁcient quenching. However, in the presence of the phospholipid
membranes, the extent of quenching was signiﬁcantly reduced,
indicating a poor accessibility of the Trp of both peptides to the
aqueous phase, consistent with its incorporation into the lipid bilayer.
This notion is substantiated by the lower Ksv values obtained from the
Stern–Volmer plots (Table 2). Signiﬁcantly, Ksv values were similar
both in the presence of negatively charged phospholipids and in the
presence of zwitterionic ones. The transverse location of the NS5A 1A
and 1B peptides into the lipid bilayer was further investigated by
monitoring the relative quenching of the Trp ﬂuorescence by the
lipophylic spin probes 5-NS and 16-NS. The variation of the
ﬂuorescence intensity as a function of the effective concentration of
both 5-NS and 16-NS probes is shown in Fig. 4C and D, whereas the Ksv
values for both probes are presented in Table 2. In general, 16-NS
quenches the peptides ﬂuorescence less efﬁciently than 5-NS, which is
consistent with the location of the Trp residues in a shallow position
in the membrane. Changes on the membrane dipole potential
magnitude elicited by the peptides were monitored by means of the
spectral shift of the ﬂuorescence probe di-8-ANEPPS [47]. The
variation of the ﬂuorescence intensity ratio R450/520 normalized as a
function of the peptide concentration for different membrane
compositions is shown in Fig. 4E and F. In the presence of the
peptides, the greater decrease in the R450/520 values weremeasured in
the presence of zwitterionic phospholipids rather than on liposomes
composed of negatively charged phospholipids. These data would
conﬁrm the presence of a speciﬁc interaction of the peptide with
vesicles and the peptides were capable of inserting into the lipid
bilayer and modifying the dipole potential. Because the NS5A 1A and
1B peptides have a negative net formal charge of −2 and −1
respectively, it is reasonable to assume that an electrostatic repulsion
underlies the results obtained with these peptides and the negatively
charged phospholipids.
The effect of the NS5A 1A and 1B peptides on the structural and
thermotropic properties of phospholipid membranes was also
investigated by measuring the steady-state ﬂuorescence anisotropy
of the ﬂuorescent probes DPH and TMA-DPH incorporated into model
membranes composed of saturated synthetic phospholipids as a
function of temperature (Fig. 5). DPH is known to partition mainly
into the hydrophobic core of the membrane, whereas TMA-DPH is
oriented at the membrane bilayer with its charge localized at the
lipid–water interface [48]. Their different locations and orientations in
the membrane allow to analyze the effect of the NS5A 1A and 1B
peptides on the structural and thermotropic properties along the full
length of the membrane. For DMPC, DMPG and DPPC bilayers, the
NS5A 1A and 1B peptides decreased slightly the cooperativity of the
thermal transition and in addition elicited a shift of about 2–4 °C to
higher temperatures of the Tm (Fig. 5A, B, C, D, G and H). However, the
anisotropy of both DPH and TMA-DPH above and below the Tm of the
phospholipids was not signiﬁcantly changed. These data suggest that
the peptides were able to perturb the phospholipid acyl chains when
compared to the pure phospholipids. In contrast, for DMPS we did not
observe a signiﬁcant decrease in cooperativity, although a slight shiftof Tm to higher temperatures was evident, more apparent for TMA-
DPH than for DPH (Fig. 5E and F). In the case of DMPA there was no
signiﬁcant change in the cooperativity of the transition, although a
shift to higher temperatures of the Tm was observed for TMA-DPH
(Fig. 5I); however, peptide 1A and peptide 1B induced a shift to lower
and higher temperatures respectively in the case of DPH (Fig. 5J). No
signiﬁcant changes in anisotropy were observed below and above the
main transition temperature. When the ER complex lipid mixture,
having DMPC instead of EPC, was analyzed, the same trend was
observed for both probes, i.e., a slight decrease of the cooperativity of
the thermal transition and no signiﬁcant change in the anisotropy
both below and above the main transition temperature (Fig. 5K
and L). These results suggest that the difference in charge between the
phospholipid headgroups affect, but slightly, the peptide incorpora-
tion into the lipid bilayer, and therefore it could be suggested that
both 1A and 1B peptides, although interacting with the membrane,
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the ﬂuidity of the phospholipids [49].
The effect of both NS5A peptides 1A and 1B on the thermotropic
phase behaviour of different phospholipid multilamellar vesicles was
assayed using differential scanning calorimetry (DSC) and the
corresponding proﬁles are shown in Fig. 6A, B and C. The incorpora-
tion of both peptides signiﬁcantly altered the thermotropic behaviour
of both DMPC and DMPG, since the peptides signiﬁcantly broadened
the transition of both phospholipids in accordance with the
anisotropy results commented above (Fig. 6A and B). In the case of
DMPC and at a lipid/peptide ratio of 15:1, the main transition is
apparently associated by at least two different peaks, which should be
due tomixed phases (Tm of 24.1 and 27 °C for peptide 1A and 23.6 and
26.1 °C for peptide 1B). The coexistence of at least two phases would
indicate that one of them would be enriched in peptide (phospho-
lipids highly disturbed) whereas the other one would be
impoverished in them (phospholipids slightly disturbed). In the
case of DMPG, the peak is broad but two peaks are not clearly
resolvable (Tm of 27.4 °C for peptide 1A and 25.9 °C for peptide 1B). By
contrast, both peptides did not broaden signiﬁcantly the Lβ–Lα main
transition of DEPE but abolished completely the presence of the
lamellar-hexagonal Lα–ΗΙΙ phase transition (Fig. 6C).
We have used 31P MAS NMR to observe the mixture EPC/ESM at a
molar ratio of 5:1 since the 31P NMR isotropic chemical shifts of both
ESM and EPC headgroups are resolvable under MAS conditions.
Furthermore, their spectral intensities reﬂect the molar ratio of each
lipid in the mixture. This approach allows the observation of the line
widths of each phospholipid component in the mixture. As observed
in Fig. 6D, the chemical shift for the EPC and ESM resonances were not
signiﬁcantly different neither in the absence nor in the presence of
both peptides, but the line widths of the 31P resonances of EPC and
ESMwere dissimilar. Apart from the ESM peak and through the use of
ﬁtting, we could distinguish two peaks for the EPC molecule, which
comprised about 56% and 44% of the total EPC area (see Fig. 6D). In theFig. 7. Stacked infrared spectra in the Amide I′ region of the NS5A-derived peptides 1A (A, B
and DMPG (C and F) at different temperatures as indicated. The phospholipid/peptide molabsence of peptides, the 31P line width at half height of the EPC
resonances was 44 Hz (peak appearing at−0.21 ppm and comprising
39% of the total area) and 75 Hz (peak appearing at −0.58 ppm and
comprising 47% of the total area). The 31P line width at half height for
the ESM peak was 52 Hz (peak appearing at 0.41 ppm, about 14% of
the total area). When peptides 1A and 1B were present, these ﬁgures
increased to 112 Hz, 81 Hz, 108 Hz and 97 Hz, 84 Hz and 92 Hz
respectively. These results show that both phospholipids, EPC and
ESM, exhibit a lower degree of mobility and/or an increased hetero-
geneity of headgroup environments in the presence of peptides 1A
and 1B [50].
The existence of structural changes on the NS5A peptides 1A and
1B induced by membrane binding was studied by analyzing the
infrared Amide I′ band located between 1700 and 1600 cm−1 in
membranes by infrared spectroscopy (Fig. 7). The Amide I′ region of
the fully hydrated peptides in buffer are shown in Fig. 7A and D. The
spectra, at low temperature, are formed by different underlying
components that give place to a broad and asymmetric band with
maxima at about 1650 cm−1 and a shoulder at about 1673 cm−1 for
peptides 1A and 1B, respectively. At higher temperatures, the
maximum of the bands does not change signiﬁcantly, since they
appear at about 1648 cm−1 and 1649 cm−1 for peptides 1A and 1B,
respectively. Interestingly, the band which appear at approximately
1673 cm−1 in both peptides 1A and 1B increases in intensity at the
same time that temperatures increases (Fig. 1A and D). Signiﬁcantly,
two other bands at about 1685 cm−1 and 1616 cm−1 appear in the
spectra of peptide 1B and increase in intensity as the temperatures is
raised (Fig. 7D). The band with the intensity maxima at about
1650 cm−1 would correspond to a mixture of unordered but also
helical structures, the band at about 1673 cm−1 would correspond to
β-sheet structures, whereas the bands at about 1685 cm−1 and
1616 cm−1 appearing at the same time should correspond to
aggregated structures [51,52]. These data would imply that peptide
1A changed from amixture of mainly helical and unordered structuresand C) and 1B (D, E and F) in solution (A and D) and in the presence of DMPC (B and E)
ar ratio was 15:1.
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structures at high temperatures. However, peptide 1B changed from a
mixture of mainly helical and unordered structures at low tempera-
tures to a mixture of aggregated structures and helical, β-sheet and
unordered structures at high temperatures. In the presence of both
DMPC (Fig. 7B and E) and DMPG (Fig. 7C and F) and at all
temperatures studied, the Amide I′ envelope of both NS5A peptides
1A and 1B was rather similar to that found for the peptides in solution
at low temperatures. These data would suggest a high degree of
conformational stability of the peptides but only in the presence of the
model membranes. These results imply that the secondary structure
of peptides 1A and 1B was affected by its binding to the membrane.
4. Discussion
The HCV replication process remains largely unclear. The replica-
tion and assembly of HCV has been suggested to occur in the
endoplasmic reticulum or derived membranes, and it is generally
believed that most, if not all, of the NS proteins are involved [6,53,54].
The fact that all NS proteins are localized together with newly
synthesized viral RNA on the endoplasmic reticulum or membranes
originating from it supports this hypothesis. However, the functions of
the individual proteins which participate in the viral replication and/
or the assembly remain poorly understood. NS5A is a membrane
protein whose function in the HCV life cycle is not known but has a
critical role in the HCV life cycle since it has been shown that it is
indispensable for replication and assembly [10–12,55,56]. Signiﬁcant-
ly, genetic disruption of the N-terminal segment of NS5A has been
shown to abrogate RNA replication [57], validating this region as a
potentially antiviral target.
Since NS5A is associated to the membrane and its function might
be modulated by it, we have carried the analysis of the membrane-
active regions of NS5A by observing the effect of a NS5A-derived
peptide library from HCV strain 1a_H77 on the integrity of two
membrane model systems [58]. Following this approach, we have
been able of discerning different peptides along the NS5A sequence
which display distinct membranotropic properties. When all the
membrane leakage values were taken into account, only one region
displayed signiﬁcant membrane rupture activity, namely the se-
quence encompassing amino acids 3 to 20 (NS5A numbering)
(Fig. 1B). Peptide segments 3–20 coincide with the fragment which
associates NS5A protein with the membrane and supposedly is
implicated in speciﬁc protein–protein interactions [15,18]. The
importance of this region is demonstrated by the fact that the
introduction of mutations into this fragment abolishes HCV RNA
replication [19]. Accordingly, we havemade a comprehensive study of
two peptides patterned after this sequence, peptides 1A and 1B,
derived respectively from the NS5A protein sequences from HCV
strains 1a_H77 and 1b_HC-J4, characterizing their binding and
interaction with model membrane systems through a series of
complementary experiments. Our ﬁndings give some clues to a key
region in the viral protein that might be implicated in the HCV life
cycle, and therefore could be used as a new target for searching
inhibitors of viral replication and assembly.
Peptides 1A and 1B bind with high afﬁnity to phospholipid model
membranes, as it has been similarly found for other peptides [38,41].
An increase in Trp anisotropy was also observed for peptides 1A and
1B in the presence of phospholipid model membranes, showing a
signiﬁcant motional restriction. Binding of peptides 1A and 1B to
liposomes was further demonstrated by hydrophilic quenching
probes, since both peptides were less accessible for quenching by
acrylamide. The peptides decreased the dipole potential of the
membrane as well, but in the presence of zwitterionic phospholipid
containing model membranes. The fact that the two peptides, as is
shown by the ﬂuorescence results, do interact in a similar way with
the membrane supports the importance of the speciﬁcity on theprimary amino acid sequence for the interaction to take effect. The
peptide should be located at the lipid–water interface inﬂuencing the
ﬂuidity of the phospholipids, most probably with an in-plane
orientation rather than in a transmembrane position as it has been
shown previously [16]. Both peptides were also capable of altering the
stability of the membrane, causing the release of ﬂuorescent probes;
this effect being dependent on lipid composition and on the lipid/
peptide molar ratio. The highest CF release was observed for
liposomes containing zwitterionic phospholipids, although signiﬁcant
leakage values were also observed for liposomes composed of
negatively charged phospholipids. Interestingly, leakage of ﬂuoro-
phores larger than CF, as FD10, was only observed in liposomes
composed of EPC and ER and in lower extent in liposomes containing
cholesterol. These differences could be a consequence of inﬂuence of
cholesterol in the membrane penetration of peptides attenuating its
insertion as it has been observed for other peptides [59]. Furthermore,
the results obtained in this study suggest that the difference in charge
between the phospholipid headgroups affect, the peptide interaction
into the lipid bilayer, since the peptides binds to zwitterionic
phospholipids with higher afﬁnity and perturbs membrane integrity
and dipole potential in a greater extent than those containing
negatively charged ones.
We have also shown that both peptides 1A and 1B are capable of
affecting the steady-state ﬂuorescence anisotropy of ﬂuorescent
probes located into the palisade structure of the membrane, since
the peptides decreased the cooperativity of phase transition of
saturated phospholipids, without the modiﬁcation of the mobility of
the phospholipid acyl chains neither below nor above it when
compared to the pure phospholipids. Additionally, by using MAS
NMR, we demonstrated that the phosphate groups of the phospho-
lipidmolecules display a lower degree of mobility and/or an increased
heterogeneity of the headgroup environment in the presence of both
peptides 1A and 1B. This result strengthens that the location of the
peptide is at or near the membrane interface. The infrared spectra of
the Amide I′ region of the fully hydrated peptides in solution changed
signiﬁcantly with temperature. However, in the presence of mem-
branes no change was observed, demonstrating a high stability of its
conformation when bound to the membranes, where a mixture of α-
helix, β-sheet and random structures coexisted. These results imply
that the secondary structure of the peptides 1A and 1B was affected
and stabilized by its binding to the membrane, so that membrane
binding modulates the secondary structure of the peptide as it has
been suggested for other peptides [38,41,49]. It should be recalled that
aggregated structures were only observed for peptide 1B in solution
and at relatively high temperatures. This can be due to the change of
the disposition of the charged amino acids to locations where they
disrupt the hydrophobic surface of the peptide.
Identifying regions within viral proteins is critical to understand
and characterize the infection process. The binding to the surface and
the modulation of the phospholipid biophysical properties which take
place when region comprising amino acids 3 to 20 of HCV NS5A
protein is bound to the membrane, i.e., partitioning into the
membrane surface and perturbation of the bilayer architecture,
could be related to the conformational changes which might occur
during the biological activity of the protein. As it has been noted
above, a peptide derived from the N-terminal fragment of NS5A and
coincidental with peptide 1A has been shown to have potent antiviral
activity against HCV and HIV [20,60]. The capacity of peptides derived
from this region to bind and modify the structure of membranes must
be behind this activity. Therefore, the NS5A region where peptides
1A and 1B reside might have an essential role in the membrane
replication and/or assembly of the viral particle through the
modulation of the replication complex. Consequently, our ﬁndings
identify an important region in the HCV NS5A protein which might be
directly implicated in the HCV life cycle. Moreover, pharmacological
disruption of N-terminal of NS5A interaction with membranes can
1223M.F. Palomares-Jerez et al. / Biochimica et Biophysica Acta 1798 (2010) 1212–1224represent the basis for a novel approach to anti-HCV therapy. A
biophysical methodology similar to the used in the present work
could be used for rapid screening of molecules designedwith this aim.
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